孕激素与GnRH拮抗剂促排卵方案整倍体囊胚率比较
这项前瞻性非劣效年龄匹配病例对照研究比较了孕激素促排卵(PPOS)与GnRH拮抗剂方案,发现每注射卵母细胞的整倍体囊胚形成率均为21%,每患者整倍体囊胚数中位数两组相似,提示PPOS不降低整倍体率。
要点
- PPOS与GnRH拮抗剂方案的整倍体囊胚率均为21%
- 每患者整倍体囊胚数中位数两组无显著差异
- PPOS可用于卵子捐赠、生育力保存及全胚冷冻患者
核心结论
- PPOS与GnRH拮抗剂方案在每患者囊胚数、整倍体囊胚数及每注射卵母细胞的整倍体胚胎数方面相似。
研究设计与样本
- 前瞻性非劣效年龄匹配病例对照研究,6个月内纳入192例接受IVF和PGT的不孕女性,共1867个注射卵母细胞获得785个囊胚。
主要发现
- 两组每卵母细胞整倍体囊胚形成率均为21%。
- PPOS组有整倍体胚胎的患者百分比为38.7(25.5-52.9),每患者整倍体囊胚总数中位数2(1.3-3.1)。
- GnRH拮抗剂组对应数值分别为42(28-53.8)和2.1(1.3-2.9),组间无显著差异。
关键数值与推荐
- PGT采用下一代测序技术。
- 主要结局指标包括每患者囊胚数、整倍体囊胚数及每注射卵母细胞的整倍体胚胎数。
临床怎么用
- 结果支持PPOS用于卵子捐赠、生育力保存、预期全胚冷冻、预计高反应或拟行胚胎植入前遗传学检测的患者。
- 仍需研究探讨PPOS对活产率的影响。
局限性
- 病例对照设计可能限制主要发现的可靠性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does the prevalence of euploid blastocysts differ between patients treated with progestin primed ovarian stimulation (PPOS) and those treated with conventional ovarian stimulation? SUMMARY ANSWER: The numbers of blastocysts and euploid blastocysts per patient and the number of euploid embryos per injected oocyte are similar for patients undergoing progestin-primed ovarian stimulation and for those undergoing conventional ovarian stimulation with GnRH antagonist. WHAT IS KNOWN ALREADY: New approaches to ovarian stimulation have been developed based on the use of drugs administrable by mouth instead of via injections. Attention has been dedicated to progestins to block the LH surge. Previous data regarding the number of oocytes retrieved and the number of good-quality embryos generated in PPOS have demonstrated similar outcomes when compared to conventional ovarian stimulation, even if some concerns regarding the quality of embryos have been advanced. STUDY DESIGN, SIZE, DURATION: This is a prospective non-inferiority age-matched case-control study. In a period of 6 months, a total of 785 blastocysts from 1867 injected oocytes obtained from 192 patients were available for analysis. PARTICIPANTS/MATERIALS, SETTING, METHODS: Infertile women undergoing IVF and preimplanation genetic testing (PGT) cycles were included. Forty-eight patients were treated with PPOS, and for each of them three age-matched historical controls (n = 144) treated with a GnRH antagonist protocol were selected. PGT was performed according to next-generation sequencing technology. MAIN RESULTS AND THE ROLE OF CHANCE: Basal characteristics were similar in the two groups; a substantial similarity of the main outcome measures in the two treatment groups has also been found. The rate of formation of euploid blastocysts per oocyte was 21% in both the two treatment groups. The percentage of patients with euploid embryos and the total number of euploid blastocysts per patient (median and interquartile range, IQR) in the PPOS group were 38.7 (25.5-52.9) and 2 (1.3-3.1), respectively. These figures were not significantly different in women treated with the GnRH antagonist protocol i.e. 42 (28-53.8) and 2.1 (1.3-2.9), respectively. LIMITATIONS, REASONS FOR CAUTION: This was a case-control study which may limit the reliability of the main findings. WIDER IMPLICATIONS OF THE FINDINGS: Our results encourage the use of PPOS, especially for oocyte donation, for fertility preservation and for patients in which total freezing of embryos is foreseen, for those expected to be high responders or candidates for preimplantation genetic testing. However, studies aiming to investigate the effect of PPOS on the live birth rate are warranted. STUDY FUNDING/COMPETING INTEREST(S): None.
引用
- La Marca A, Capuzzo M, Sacchi S, et al. Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation. Hum Reprod. 2020. PMID: 32395749. doi:10.1093/humrep/deaa068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。